Följ
Stefania Orecchioni
Stefania Orecchioni
European Institute of Oncology
Verifierad e-postadress på ieo.it
Titel
Citeras av
Citeras av
År
Paradoxic effects of metformin on endothelial cells and angiogenesis
K Dallaglio, A Bruno, AR Cantelmo, AI Esposito, L Ruggiero, S Orecchioni, ...
Carcinogenesis 35 (5), 1055-1066, 2014
1502014
The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells
S Orecchioni, F Reggiani, G Talarico, P Mancuso, A Calleri, G Gregato, ...
International journal of cancer 136 (6), E534-E544, 2015
1402015
Complementary Populations of Human Adipose CD34+ Progenitor Cells Promote Growth, Angiogenesis, and Metastasis of Breast Cancer
S Orecchioni, G Gregato, I Martin-Padura, F Reggiani, P Braidotti, ...
Cancer research 73 (19), 5880-5891, 2013
1142013
Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer …
S Orecchioni, G Talarico, V Labanca, A Calleri, P Mancuso, F Bertolini
British journal of cancer 118 (10), 1329-1336, 2018
822018
Adipose progenitor cell secretion of GM-CSF and MMP9 promotes a stromal and immunological microenvironment that supports breast cancer progression
F Reggiani, V Labanca, P Mancuso, C Rabascio, G Talarico, S Orecchioni, ...
Cancer research 77 (18), 5169-5182, 2017
732017
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target
MR Sapienza, F Abate, F Melle, S Orecchioni, F Fuligni, M Etebari, ...
haematologica 104 (4), 729, 2019
712019
Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells
G Talarico, S Orecchioni, K Dallaglio, F Reggiani, P Mancuso, A Calleri, ...
Scientific reports 6 (1), 18673, 2016
622016
Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors
D Sanchez-Martinez, N Allende-Vega, S Orecchioni, G Talarico, ...
Theranostics 8 (14), 3856, 2018
592018
Human leukemic cells performing oxidative phosphorylation (OXPHOS) generate an antioxidant response independently of reactive oxygen species (ROS) production
AUH Khan, MG Rathore, N Allende-Vega, DN Vo, S Belkhala, ...
EBioMedicine 3, 43-53, 2016
572016
Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells
V Salvestrini, S Orecchioni, G Talarico, F Reggiani, C Mazzetti, F Bertolini, ...
Oncotarget 8 (4), 5895, 2017
552017
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells’ vulnerability to DNA-damaging agents
A Cagnetta, D Soncini, S Orecchioni, G Talarico, P Minetto, F Guolo, ...
haematologica 103 (1), 80, 2018
532018
Stromal Cell-Derived Factor-1α Promotes Endothelial Colony-Forming Cell Migration Through the Ca2+-Dependent Activation of the Extracellular Signal …
E Zuccolo, C Di Buduo, F Lodola, S Orecchioni, G Scarpellino, DA Kheder, ...
Stem cells and development 27 (1), 23-34, 2018
462018
The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia
M Allegretti, MR Ricciardi, R Licchetta, S Mirabilii, S Orecchioni, ...
Scientific reports 5 (1), 18137, 2015
442015
The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism
N Allende-Vega, E Krzywinska, S Orecchioni, N Lopez-Royuela, ...
Oncotarget 6 (22), 19228, 2015
412015
Mitochondrial Complex I activity signals antioxidant response through ERK5
AUH Khan, N Allende-Vega, D Gitenay, J Garaude, DN Vo, S Belkhala, ...
Scientific reports 8 (1), 7420, 2018
362018
Cyclophosphamide and vinorelbine activate stem-like CD8+ T cells and improve anti-PD-1 efficacy in triple-negative breast cancer
P Falvo, S Orecchioni, R Hillje, A Raveane, P Mancuso, C Camisaschi, ...
Cancer Research 81 (3), 685-697, 2021
352021
Application of fat grafting in cosmetic breast surgery
MJ Davis, AT Perdanasari, A Abu-Ghname, SR Gonzalez, E Chamata, ...
Seminars in Plastic Surgery 34 (01), 024-029, 2020
312020
The combination of the PARP inhibitor rucaparib and 5FU is an effective strategy for treating acute leukemias
MVV Falzacappa, C Ronchini, M Faretta, I Iacobucci, AGL Di Rorà, ...
Molecular cancer therapeutics 14 (4), 889-898, 2015
312015
Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant–associated anaplastic large cell lymphomas
V Tabanelli, C Corsini, S Fiori, C Agostinelli, A Calleri, S Orecchioni, ...
Human Pathology 90, 60-69, 2019
302019
The PDK1 inhibitor dichloroacetate controls cholesterol homeostasis through the ERK5/MEF2 pathway
AUH Khan, N Allende-Vega, D Gitenay, S Gerbal-Chaloin, C Gondeau, ...
Scientific reports 7 (1), 10654, 2017
272017
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20